🆕
www.calicolabs.com
27/06/2026
Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease - Calico
South San Francisco, Calif., June 23, 2026 – Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related diseases ...